References
- DeVita MV, et al. Incidence and etiology of hyponatremia in an intensive care unit. Clin Nephrol 1990; 34: 163–6
- Bennani SL, et al. Incidence, causes and prognostic factors of hyponatremia in intensive care. Rev Med Interne 2003;24:224–9 ( in French).
- Adler SM, Verbalis JG. Disorders of body water homeostasis in critical illness. Endocrinol Metab Clin North Am 2006; 35: 873–94
- Siragy HM. Hyponatremia, fluid-electrolyte disorders, and the syndrome of inappropriate antidiuretic hormone secretion: diagnosis and treatment options. Endocr Pract 2006; 12: 446–57
- Palmer BF. Hyponatraemia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol Dial Transplant 2000; 15: 262–8
- Rabinstein AA, Wijdicks EF. Hyponatremia in critically ill neurological patients. Neurologist 2003; 9: 290–300
- Rabinstein AA. Vasopressin antagonism: potential impact on neurologic disease. Clin Neuropharmacol 2006; 29: 87–93
- Sherlock M, et al. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf) 2006; 64: 250–4
- McGirt MJ, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 2004;54:1369–73; discussion 1373–4.
- Tsubokawa T, et al. Clinical significance of natriuretic peptides in patients with aneurysmal subarachnoid hemorrhage. No To Shinkei 2003;55:953–60 (in Japanese).
- Wartenberg KE, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006;34:617–23; quiz 624.
- Sviri GE, Soustiel JF, Zaaroor M. Alteration in brain natriuretic peptide (BNP) plasma concentration following severe traumatic brain injury. Acta Neurochir (Wien) 2006;148:529–33; discussion 533.
- Kirchhoff C, et al. Intrathecal and systemic concentration of NT-proBNP in patients with severe traumatic brain injury. J Neurotrauma 2006; 23: 943–9
- Namba T, et al. Cerebral salt wasting syndrome in a patient with viral meningoencephalitis. Nippon Jinzo Gakkai Shi 2006;48:669–74 ( in Japanese).
- Latado AL, et al. Predictors of in-hospital lethality in patients with advanced heart failure. Arq Bras Cardiol 2006; 87: 185–92
- Biggins SW, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652–60
- Biggins SW, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41: 32–9
- Kim DJ, et al. Prognosis after liver transplantation predicted by preoperative MELD score. Transplant Proc 2006; 38: 2095–6
- Wijdicks EF, et al. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful?. Ann Neurol 1985; 17: 137–40
- Wijdicks EF, et al. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol 1985; 18: 211–6
- Reynolds RM, Seckl JR. Hyponatraemia for the clinical endocrinologist. Clin Endocrinol (Oxf) 2005; 63: 366–74
- Schrier RW, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006; 355: 2099–112
- Goldsmith SR. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure. Am J Cardiol 2005; 95(Suppl 9A)14B–23